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Site-to-site interdomain 
communication may mediate 
different loss-of-function 
mechanisms in a cancer-associated 
NQO1 polymorphism
Encarnación Medina-Carmona1, Jose L. Neira2,3, Eduardo Salido4, Julian E. Fuchs5, 
Rogelio Palomino-Morales6, David J. Timson7 & Angel L. Pey1
Disease associated genetic variations often cause intracellular enzyme inactivation, dysregulation 
and instability. However, allosteric communication of mutational effects to distant functional sites 
leading to loss-of-function remains poorly understood. We characterize here interdomain site-to-site 
communication by which a common cancer-associated single nucleotide polymorphism (c.C609T/p.
P187S) reduces the activity and stability in vivo of NAD(P)H:quinone oxidoreductase 1 (NQO1). NQO1 
is a FAD-dependent, two-domain multifunctional stress protein acting as a Phase II enzyme, activating 
cancer pro-drugs and stabilizing p53 and p73α oncosuppressors. We show that p.P187S causes 
structural and dynamic changes communicated to functional sites far from the mutated site, affecting 
the FAD binding site located at the N-terminal domain (NTD) and accelerating proteasomal degradation 
through dynamic effects on the C-terminal domain (CTD). Structural protein:protein interaction 
studies reveal that the cancer-associated polymorphism does not abolish the interaction with p73α, 
indicating that oncosuppressor destabilization largely mirrors the low intracellular stability of p.P187S. 
In conclusion, we show how a single disease associated amino acid change may allosterically perturb 
several functional sites in an oligomeric and multidomain protein. These results have important 
implications for the understanding of loss-of-function genetic diseases and the identification of novel 
structural hot spots as targets for pharmacological intervention.
Native proteins are heterogeneous ensembles sampling a wide variety of microscopic conformations1. The rela-
tive population of these states is determined by their intrinsic stabilities (i.e. free energies) as well as their rates of 
interconversion (i.e. kinetic barriers)1,2. Large-scale and slow collective motions (in the ms to s time scales) deter-
mine the transitions between a small number of low energy states that correspond to different conformational 
states (with intrinsically different structure and energetic balance)1–4. Within these low energy states, small-scale 
fluctuations rapidly occur, such as backbone and side-chain dynamics, which are the main source of conforma-
tional dynamics1,3,4. A deep structural, thermodynamic and kinetic understanding of collective and local protein 
motions is essential to understand protein function, regulation, degradation and evolution4–10.
Protein allostery is the phenomenon that allows communication between two distant sites in a protein (e.g. 
two binding sites for different ligands or between a ligand binding and a mutated/post-translational modification 
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site)11. Ligand binding remodels protein conformational ensembles by stabilizing binding competent states from 
such a conformationally heteregenous pre-existing equilibrium. The consequent population-shift of microstates 
is macroscopically observed as a conformational change11–14. Accordingly, structural and dynamic aspects of these 
conformational changes have significant impact on protein function and regulation (e.g. on ligand binding affin-
ity and energetics)2–4,12,15. A combination of functional, structural and thermodynamic analyses is a powerful 
approach to identify allosteric networks and pathways in proteins and to distinguish between different allosteric 
mechanisms (e.g. induced-fit vs. conformational selection)4,12,14,16.
Disease-associated inherited changes in protein sequence (i.e. mutations and polymorphisms) affect protein 
activity, regulation and stability17–22. However, allosteric site-to-site communication underlying loss-of-function 
genetic variations has rarely been investigated in multi-domain oligomeric proteins23–25. Here, we hypothesize that 
the cancer-associated single nucleotide polymorphism p.P187S (rs1800566/c.C609T) in the NADP(H):quinone 
oxidoreductase 1 (NQO1; EC 1.6.5.2) mediates enzyme loss-of-function through long-range site-to-site effects 
originating at the p.P187S site and communicated to distant functional sites through a hypothetical allosteric inter-
action network (Fig. 1). NQO1 is a two-domain FAD-dependent enzyme (Fig. 1A,B) involved in the two-electron 
reduction of quinones, important for Phase II detoxification reactions, superoxide scavenging and activation of 
certain cancer pro-drugs26. The N-terminal domain (NTD) binds FAD and the smaller C-terminal domain (CTD, 
residues 225–274) is structurally involved in binding of NADH, substrates and competitive inhibitors (e.g. dicou-
marol) (Fig. 1B,C). NQO1 also interacts with and stabilizes cancer-associated transcription factors such as p53 
and p73α 27–30, even though the structural basis of this intracellular interaction is unknown. Although p.P187S 
strongly reduces NQO1 levels and activity in vivo, crystallographic analyses of holo-p.P187S have shown no 
significant effect on functional or structural sites such as FAD binding site, the CTD or the monomer:monomer 
interface31. However, molecular dynamics (MD) simulations, biophysical experiments and expression analyses 
have supported the hypothesis that p.P187S inactivates and destabilizes NQO1 through dynamic changes in the 
apo-state, in particular on two functionally and structurally distant sites (Fig. 1D): the FAD binding site, associ-
ated with enzyme inactivation; and the CTD, associated with enhanced proteasomal degradation of p.P187S22,24,31.
In this work, we investigate how the p.P187S polymorphism affects the FAD binding site and the CTD of 
NQO1 through long-range communication of structural and dynamic perturbations (Fig. 1D), as well as their 
potential effects on the binding site of oncosuppresors. To do so, we characterize wild-type (WT) and p.P187S 
NQO1 in their full-length and C-terminal truncated (Δ 50-NQO1) forms using a multi-disciplinary approach. 
Overall, we show how a single amino acid substitution may cause protein loss-of-function by simultaneously 
affecting multiple functional sites in a complex oligomeric and multidomain protein with metabolic and regula-
tory roles.
Results
The CTD of NQO1 plays an important role in the conformational equilibrium of the apo-state. 
Structural analyses32 have shown that the CTD forms part of NQO1 dimer interface (Fig. 1A,B), adding up to 
35% of the total buried surface at this interface (960 Å2 of 2700 Å2 per monomer; calculated using cpptraj33). 
Calculations using the PISA server (http://www.ebi.ac.uk/pdbe/pisa/34) reveal that at least one residue of the CTD 
is involved in 40% of the hydrogen bonds and half of the salt bridges at the dimer interface. In addition, the CTD 
forms part of the dicoumarol binding site (Phe232 and Phe236; Fig. 1C), but it does not seem essential for FAD 
binding or stable folding of the NTD (Figure S131). While Pro187 is not close to the FAD or dicoumarol binding 
sites, its shortest distance to the CTD is about 4 Å (with Gln268 and Ile269) (Fig. 1B,D). Therefore, it is unclear 
whether deletion of the CTD affect the dimerization, activity and stability of NQO1, as well as the structural and 
dynamic effects caused by p.P187S on the FAD binding site and the CTD (Fig. 1C,D and ref. 24).
NQO1 WT and p.P187S in their full-length and C-terminal deleted (lacking the last 50 residues at the 
C-terminus, Δ 50-NQO1) versions were expressed in and purified from E. coli. To investigate their oligomeric 
state, their hydrodynamic behavior was analyzed by size-exclusion chromatography (SEC) and dynamic light 
scattering (DLS) (Figure S2A and S2B). Our results show that all NQO1 variants behave as dimers in solution 
even at concentrations ≤ 1 μ M (note that dimers of NQO1 and Δ 50-NQO1 are expected to have a molecular 
weight of 65.2 and 53.9 kDa, respectively). The 1-1 echo pulse sequence of NQO1 WT and P187S mutant were 
also used to measure T2 relaxation times of the most down-field isolated amide protons of both spectra, yielding a 
molecular weight of approximately 78 kDa (at 20 μ M concentration in monomer units; see Supplementary infor-
mation). We attempted to detect dimer dissociation and to determine their dissociation constants by isothermal 
titration calorimetry (ITC; Figure S2C). However, dilution of NQO1 dimer caused little or no heat change com-
pared to the blank (i.e. buffer) dilution heats, thus supporting that dissociation of dimers in the low micromolar 
range initially used during titrations occurs to little or negligible extent. This result is important considering that 
the amount of surface exposed to the solvent upon dimer dissociation (expected to be about 5400 Å2; see above) 
would give a remarkable heat release, in the 10–15 kcal·mol−1 range at 25 °C, using the previously published 
structure-energetics correlations35.
Remarkably, NQO1 proteins as purified show different amounts of FAD bound, with WT having the highest 
content, Δ 50-WT showing intermediate levels (about 4-fold lower than for WT), and p.P187S and Δ 50-p.P187S 
displaying negligible levels of bound FAD, as judged from their corresponding absorption near-UV/visible spec-
tra (Fig. 2A). To investigate their overall conformation, we have prepared apo-proteins and then added precise 
concentrations of ligands to achieve different ligation states (holo-NQO1, with FAD, and holo-NQO1+ dicouma-
rol, with an excess of FAD and dicoumarol). The far-UV circular dichroism (CD) spectra of full-length and Δ 50 
apo-proteins show a high content of ordered secondary structure (Fig. 2B–E). Binding of FAD alters the second-
ary structure content, increasing the ellipticity at 222 nm (a hallmark for α -helical content) by 20–25% in all cases 
except for p.P187S in which this increase is of 10% (Fig. 2F,G; note that in all cases, a statistical comparison of a 
given variants as holo- vs. apo-protein yields a p value < 0.05 using a t-test). Binding of dicoumarol, that interacts 
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with both NTDs and CTDs in full-length NQO1, leads to further increase of 16% in holo-p.P187S (p < 0.05) 
but not in holo-WT, while it causes only small increments (6–9%) in Δ 50 variants (Fig. 2F,G). Since apo-NQO1 
intrinsically populates partially unfolded conformations22,24,31,36, these results suggest that binding of FAD and 
dicoumarol to full-length and Δ 50 variants leads to a shift in the conformational equilibrium of NQO1 towards 
more compact, ligand binding competent conformations. Accordingly, DLS experiments showed a decrease in 
the hydrodynamic radii of WT and p.P187S when FAD or FAD + dicoumarol are added, respectively (Fig. 2H), 
further supporting a more compact average dimer conformation in the presence of these ligands. In the case of 
Figure 1. NQO1 structure, dimerization and functional definition of the hypothetical allosteric interaction 
network. (A) Two views of the NQO1 dimer showing the protein surface and the dimerization interface (as 
calculated using the PISA server34); the N-terminal domains (NTD) are displayed in red (monomer #1) and 
brown (monomer #2) while the C-terminal domains (CTD) are displayed in blue (monomer #1) and cyan 
(monomer #2); (B) Two views of the NQO1 dimers displaying secondary structures of NTD (residues 2-225, in 
blue) and the CTD (residues 226–271, in red). FAD, dicoumarol (dic) and P187 are shown in cyan, light brown 
and green, respectively. (C) Close-up view of the FAD and dicoumarol binding sites, with the residues belonging 
to the NTD (blue) and CTD (red) highlighted. (D) Schematic representation of the hypothesized allosteric 
interaction network involving the p.P187S and FAD binding sites and the CTD. In the FAD binding site (left 
panel), the highly dynamic loop 57–66 in the apo-state of p.P187S is indicated with a cyan arrow to highlight its 
far location from the CTD and p.P187S sites. Structures were displayed with Pymol60 using the NQO1 structure 
(PDB:2F1O).
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the Δ 50 variants, binding of FAD and/or dicoumarol led to much smaller effects on the hydrodynamic radius 
(Fig. 2H) indicating an important role of the CTD in the conformational equilibrium of apo-NQO1.
The dynamic CTD of p.P187S neither contributes to its low in vitro kinetic stability nor to ligand 
mediated stabilization of NQO1 dimers. p.P187S strongly decreases the in vitro thermal and kinetic 
stability of NQO1 by accelerating dimer unfolding and dissociation22,24. To investigate the role of the CTD on its 
Figure 2. Conformational analysis of NQO1 variants. (A) FAD bound to the proteins as purified from 
Near-UV/visible absorption spectra. (B–E) Far-UV CD spectra of NQO1 variants as apo-proteins, in the 
presence of FAD (Holo) or FAD + dicoumarol (Holo + dic); (F,G) values of mean residue ellipticity ([Θ ]MRE) at 
222 nm from spectra shown in panels (B–E,H) hydrodynamic radius for NQO1 variants in the different ligation 
states. Data in panels A–G are the average from three independent experiments, while in panel H are from 3 to 6 
independent experiments. Values in panels F, G and H are mean ± s.d. from replicates. In all cases, two to three 
different protein purifications were used, and the temperature was 25 °C.
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low kinetic stability, we have performed thermal denaturation studies monitored by CD spectroscopy (Fig. 3). 
Removal of CTD causes a small 3 °C destabilization on the WT and p.P187S backgrounds (Fig. 3 and Table 1). A 
large excess of FAD (holo-proteins) causes a remarkable stabilization, ranging from 5 to 10 °C (Fig. 3 and Table 1), 
and an excess of FAD and dicoumarol have a roughly additive effect on stability (from 12–17 °C). These results 
imply that removal of CTD modestly destabilizes NQO1, and it is not the cause the low in vitro kinetic stability 
of p.P187S.
Partial proteolysis of full-length NQO1 proteins provides quantitative information on the effects of poly-
morphisms and ligand binding on local dynamics24. Partial proteolysis of Δ 50 variants as apo-proteins showed 
a rapid decay of the native protein (Fig. 4A,B), and the appearance of 3–4 proteolysis products with molecular 
sizes of 16–19 kDa (Table S1) based on HPLC/ESI-MS. FAD binding causes a remarkable 10-fold increase in 
Figure 3. Thermal stability of NQO1 variants. Experiments were performed using NQO1 variants in different 




Apo Holo Holo + dic
WT 50.4 55.7 63.7
p.P187S 42.6 49.9 58.7
Δ 50-WT 47.9 54.5 59.3
Δ 50-p.P187S 39.5 48.7 56.3
Table 1.  Thermal stability of NQO1 and Δ50 variants. The apparent melting temperatures (Tm) are 
determined for proteins as apo-proteins, and in the presence of FAD or FAD + Dicoumarol.
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the resistance towards degradation (Fig. 4A,B) and the accumulation of 18 and 15 kDa partially proteolyzed 
species (Table S1). Binding of dicoumarol to holo-proteins leads to a 10–20 fold additional stabilization of the 
native Δ 50 protein (Fig. 4A,B). Peptide fingerprinting of digested samples by MS/MS revealed that cleavage is 
initiated in the C-terminal part of Δ 50-NQO1, involving several active cleavage sites in the region 150–170 
(particularly dynamic in the apo-state of Δ 50-NQO1, see our MD simulations below) leading to the formation 
of a stable intermediate comprising residues 1–143 (Figs 4A and S3). Our comparative analyses of proteolysis 
kinetics supports our previous proposal of a very dynamic CTD in the apo-state of NQO1, that remains dynamic 
in the holo-p.P187S unless dicoumarol is bound (Fig. 4C). We must note that an absolute comparison of local 
dynamics between NQO1 and Δ 50 variants is not possible because experimental proteolysis rate constants are 
proportional to the sequence-dependent intrinsic proteolysis rate constants for primary cleavage sites under the 
conditions used.
Figure 4. Partial proteolysis of Δ50-NQO1 variants. (A) representative SDS-PAGE gels of degradation 
kinetics of Δ 50-WT in different ligation states (apo, holo and holo-holo + dic). The regions corresponding to 
molecular sizes from 45 to 14 kDa bands are shown for sake of clarity (see Figure S3 for additional pictures of 
gels); (B) Time-course of the degradation of the native band of Δ 50 variants. Experiments performed at 25 °C in 
the presence of 0.1 μ M of thermolysin. (C) proteolysis rate constants for full-length and Δ 50-NQO1 variants in 
different ligation states (data for full-length variants are from ref. 24).
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7Scientific RepoRts | 7:44532 | DOI: 10.1038/srep44532
The CTD of p.P187S undergoes a large conformational rearrangement upon dicoumarol bind-
ing and contributes to long-range dynamic effects affecting FAD binding. The low intracellular 
specific activity of p.P187S is largely associated with defective FAD binding (Fig. 5A and ref. 24). Removal of the 
CTD causes a large decrease in specific activity, that arises from a reduction in catalytic performance rather than 
in FAD content, since saturation with FAD only causes a modest increase in activity (Fig. 5A). The enzyme kinetic 
parameters for NADH and the substrate DCPIP (2,6-dichlorophenolindophenol) of holo-enzymes have been 
determined (Fig. 5B–E), revealing little effect of p.P187S on catalytic performance, while removal of the CTD 
leads to a 30-to-100-fold reduction in specific activity, and importantly, to a decrease in the apparent affinity for 
NADH by 30-to-50-fold (Fig. 5B–E and Table 2). These results confirm that p.P187S and deletion of the CTD 
cause NQO1 inactivation through different mechanisms: the former by reducing FAD binding affinity and the 
latter by strongly decreasing catalytic performance.
At this stage, we hypothesized that the CTD may particularly affect the catalytic performance of p.P187S 
in vivo due to long-range communication with FAD binding sites (Fig. 1D). NQO1 WT displays 10–100 higher 
Figure 5. Enzyme kinetic analyses of NQO1 variants. (A) Activity measurements in the absence (NQO1) or 
the presence (Holo) of a FAD excess, using 70 μ M DCPIP and 1 mM NADH. Please, note the logarithmic scale 
of the y-axis. (B) Activity dependence on NADH (B,D) and DCPIP (C,E) concentrations for WT/p.P187S (B,C) 
and Δ 50-WT/Δ 50-p.P187S (D,E). Lines are fits to the Michaelis-Menten equation.
www.nature.com/scientificreports/
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affinity for FAD than that of p.P187S and some degree of negative cooperativity22, making a robust comparison 
of their binding energetics difficult. Nevertheless, removal of the CTD abolishes the negative cooperativity of 
NQO1 WT (as seen by the good description of their binding isotherms using a non-cooperative binding model; 
Figure S4A) and also the deleterious effect of p.P187S on FAD binding, with WT and p.P187S truncated forms 
showing similarly high binding affinities and thermodynamic signatures (Fig. 6A,B). Notably, removal of the 
CTD increases the affinity of p.P187S by 4-fold due to a modest favourable entropic contribution to binding 
(Fig. 6C). These results reveal a contribution of the CTD to FAD binding affinity, playing opposite roles in WT 
and p.P187S, probably through long-range site-to-site communication between the p.P187S and functional CTD 
and FAD binding sites. This is particularly interesting because removal of CTD has little or no structural and 
dynamic effects on the FAD binding mode of holo-p.P187S31 (Figure S1 and the next section), thus indicating that 
communication between the p.P187S and functional sites mainly operates on the conformational equilibrium of 
the apo-state of p.P187S. Furthermore (see the next section), the entropic origin of the lower FAD binding affinity 
of p.P187S supports that it primarily arises from changes in protein conformational dynamics (i.e. conformational 
entropy, see Fig. 6C and the next section).
As purified, p.P187S binds dicoumarol with 90-fold lower affinity than NQO1 WT (Fig. 6D). This is mostly 
due to a much lower favourable enthalpic contribution, largely compensated by a more favourable entropic 
change (Fig. 6E). This large difference in affinity is likely explained by the much lower FAD content of p.P187S 
as purified. According to earlier crystallographic analyses and MD simulations24,32, dicoumarol binding must 
be favoured by bound FAD (i.e. in the holo- vs. the apo-state), primarily through stronger (enthalpy-driven) 
interactions that would be counterbalanced by a large decrease in protein dynamics (i.e. loss of conformational 
entropy). Consistently, binding of dicoumarol to the holo-enzymes (i.e. saturated with FAD) shows 5-fold (WT) 
and 75-fold (p.P187S) higher affinities than those found for the proteins as purified (Figs 6F and S4B). These 
results show the important structural and energetic roles of FAD in the efficient binding of dicoumarol, and also 
indicate differences in dicoumarol binding to the holo-forms of p.P187S and WT. Indeed, binding of dicouma-
rol to holo-p.P187S shows a much larger favourable enthalpic contribution (about − 21 kcal·mol−1) which is 
compensated by a large decrease in entropy (Fig. 6G). A plausible explanation for this could be a large loss of 
solvation/conformational entropy counterbalanced by the structural reorganization of the protein, particularly 
at the highly dynamic CTD of p.P187S. In fact, simple structure-energetic correlations for protein folding35 pro-
vides an enthalpy change at 25 °C of ∼ 0.21 kcal·mol−1·(residue)−1, consistent with a much larger conformational 
rearrangement (roughly a hundred residues) in p.P187S upon dicoumarol binding. According to this, dicoumarol 
binding to holo-Δ 50-WT and holo-Δ 50-p.P187S is very similar (Figure S4C), confirming that dicoumarol bind-
ing to the full-length holo-p.P187S is associated with large structural and dynamic rearrangements at its CTD 
(Fig. 6G,H).
Molecular dynamics (MD) simulations support the role of the CTD in the communication 
between p.P187S and FAD binding sites. Molecular dynamics (MD) simulations have shown that 
p.P187S affects fast internal protein dynamics through long-range effects affecting the FAD binding site and the 
CTD24. To investigate whether CTD removal could intefere with the dynamic communication between p.P187S 
and the FAD binding sites, we performed MD simulations on Δ 50-NQO1 variants, and analyzed their backbone 
dynamics using two relevant parameters24: B-factors (Fig. 7) and dihedral entropies (Figure S5).
Removal of the CTD increases the average flexibility of NQO1, particularly at the dimer interface, consist-
ent with its modest in vitro kinetic destabilization, while thermal stabilization upon FAD and dicoumarol bind-
ing correlates well with ligand mediated reduction of global dynamics (Figs 7A,B and S5A-B). Interestingly, the 
decreased binding affinity for FAD in Δ 50-NQO1 WT seems to originate from larger conformational fluctu-
ations in the FAD binding site of the apo-state (at residues 57–66, 125–136 and 150–166; Figs 7C and S5C). 
Importantly, we observe that the CTD is essential for p.P187S to enhance local dynamics in the FAD binding 
site of the apo-state, particularly at the 57–66 loop (Fig. 7D). Therefore, our MD simulations explain at atomic 
resolution how removal of the CTD significantly enhances the binding affinity of p.P187S by a modest reduction 
of binding (conformational) entropy. Therefore, the CTD has opposite effects on the FAD binding site dynamics 
of WT and p.P187S in the apo-state (Fig. 7C,D), in agreement with our experimental observations (ref. 22 and 
Fig. 6A–C). Accordingly, CTD truncated forms of WT and p.P187S show similar FAD binding energetic and 
dynamic signatures (Figs 6B, 7E and S5E).
Regarding dicoumarol binding, holo-p.P187S binds the inhibitor with two-fold lower affinity than the 
truncated version due to a large entropic penalty counterbalanced by a large favorable enthalpic contribution 
(Fig. 6F–H). This can be explained via a large conformational restriction (i.e. a decrease in conformational 
entropy) of the region 231–236 upon binding (that includes Phe232 and Phe236, which directly interact with 
dicoumarol; Figs 1C, 7G, S5G and ref. 24). Moreover, this large conformational restriction, in turn, is enthalpically 
NQO1 variant
NADH DCPIP
kcat (s−1) KM (μM) kcat (s−1) KM (μM)
WT 177 ± 7 158 ± 21 199 ± 11 13 ± 2
p.P187S 124 ± 10 210 ± 48 160 ± 58 26 ± 20
Δ 50-WT 6.6 ± 1.0 6422 ± 1668 1.3 ± 0.3 12 ± 8
Δ 50-p.P187S 5.8 ± 0.3 9985 ± 797 0.74 ± 0.07 7 ± 3
Table 2.  Enzyme kinetic parameters for holo NQO1 and Δ50 variants.
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compensated by the additional interactions established in the dicoumarol binding site at the CTD of p.P187S and 
the conformational change triggered upon binding.
Structural analyses of the interaction of NQO1 variants with the SAM domain of p73α show 
that an active NQO1 is not required for binding. Previous biochemical experiments have supported 
a role for the CTD in the interaction of NQO1 with oncosuppressors such as p73α . These interactions seem to 
be strengthened in the presence of NADH bound to NQO1 (even though this state is expected to be unstable, 
undergoing FAD reduction to FADH2 and subsequent NAD+ release), and may be inhibited by dicoumarol30 but 
not by the mechanism-based inhibitor ES936 which also interacts with the CTD32. Truncation of the CTD (resi-
dues 209–274) or the presence of the intracellularly unstable p.P187S also seem to weaken these protein:protein 
interactions29,37.
In addition to the transactivation domain, p73 also contains a sequence-specific DNA binding domain and 
an oligomerization region. Particularly, the p73α splicing variant has an extended C-terminus containing a ster-
ile alpha motif (SAMp73) capable of repressing the function of p73 transactivation domain38, and seemingly 
involved in the interaction with NQO130. Therefore, we carried out NMR (HSQC) measurements on the interac-
tions between NQO1 and SAMp73 using purified proteins. In the presence of NQO1 WT, the HSQC spectra of 
Figure 6. Thermodynamics of FAD and dicoumarol binding to NQO1 proteins. (A–C) Binding affinity 
(A) and thermodynamic profiles for FAD binding (B). In panel C, the effect of C-terminal withdrawal in 
thermodynamic binding parameters for p.P187S is shown. (D,E) Dicoumarol binding affinity (D) and 
thermodynamic binding profiles (E) for WT and p.P187S as purified. (F–H) Binding affinity (F) and 
thermodynamic profiles for dicoumarol binding (G) to holo-proteins. In panel H, the effects of C-terminal 
deletion in thermodynamic binding parameters are displayed.
www.nature.com/scientificreports/
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Figure 7. Dynamic effects (B-factors) of CTD truncation of NQO1 and ligand binding investigated by MD 
simulations. (A,B) Effects on the global (A) and dimer interface (B) dynamics of full-length and truncated 
NQO1 variants in different ligation states (apo, holo, and holo + dicoumarol); (C,D) Difference between 
C-terminal truncated and full length dynamics for WT (C) and p.P187S (D) in different ligation states;  
(E–G) Difference between p.P187S and WT as full-length and C-terminal truncated proteins in different 
ligation states ((E), apo; (F), holo; (G), holo + dicoumarol).
www.nature.com/scientificreports/
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SAMp73 showed changes in the broadening or the chemical-shifts of the cross-peaks of a set of residues which 
are spatially close (Table S2), particularly in amino acids around Gly513 of SAMp73 and those involved in the 
N-terminal helix (Fig. 8A). Addition of NADH did not alter the set of residues affected by the presence of NQO1 
WT, indicating that this interaction is not strictly NADH-dependent. Using fluorescence and far-UV CD spec-
troscopies (Fig. 8B–E), we also observed modest but reproducible structural changes upon NQO1:SAMp73 
binding, and addition of NADH seemed to increase the extent of these structural changes. Attempts to provide 
quantitative data on the affinity for the interaction between NQO1 and SAMp73 by fluorescence and ITC were 
experimentally challenging, due to the apparent low affinity (possibly in the high micromolar range) and unstable 
calorimetric baselines (Figure S6 and data not shown). Since HSQC experiments showed that the spectrum of 
SAMp73 was not largely varied upon addition of NQO1, the changes observed are likely to occur in the envi-
ronment of aromatic residues (Trp and Tyr) and the secondary structure of NQO1. Regarding SAMp73, Gly513 
showed the largest changes in CSP (0.03) (Figure S7), while most of the affected cross-peaks showed broadening 
changes suggesting intermedium-slow kinetics for complex formation (within the NMR time scale), consistent 
with a low affinity interaction. Although the changes in chemical shifts observed were small, similar variations in 
Figure 8. Structural analysis of the interaction between NQO1 and SAMp73. (A) Structure of SAMp73 
(PDB: 1COK) showing the residues (in sticks) which were affected (either by signal broadening or by a 
CSP ≥ 0.01 ppm) (BRMB number 4413) by the presence of NQO1 WT as purified. The α -helices of SAMp73 are 
displayed with different colours (red for the first one; blue for the second; purple for the short 310-helix; gold for 
the fourth α -helix; and yellow for the fifth). The figure was produced with Pymol60. (B,C) Fluorescence spectra 
(upon excitation at 280 nm) of 2 μ M SAMp73 or NQO1 WT, their sum, and the spectra of an equimolar mixture 
(2 μ M of each protein in monomer units). (D,E) Far-UV CD spectra of 10 μ M SAMp73 or NQO1 WT, their 
sum, and the spectra of an equimolar mixture (10 μ M of each protein in monomer units). In (B–E), spectra in 
the absence or the presence of NADH are shown in different panels.
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chemical shifts have been observed in other systems39. These results support that the interaction between NQO1 
WT and SAMp73 is not strictly dependent on the presence of NADH, but instead, NADH binding and reduction 
of FAD might facilitate complex formation.
The interaction of p.P187S and Δ 50-WT with SAMp73 caused similar broadening in a set of signals to those 
found for NQO1 WT (Table S2). Δ 50-WT in the presence of NADH induced broadening of all cross-peaks, 
and even those of Tyr487 (Ile541), Asp490, Asn504 (Met539), Gly513, Ser516, Glu535, Leu545 and Gly551 dis-
appeared completely (there is signal overlapping between Tyr487 and Ile541, and Asn504 and Met539). Thus, 
removal of the CTD, the presence of p.P187S or the absence of FAD bound (note that p.P187S is essentially an 
apo-protein as purified) do not abolish the interaction with SAMp73 but somewhat change the interaction mode. 
Interestingly, the binding mode of SAMp73 to NQO1 WT is also affected by the presence of dicoumarol, showing 
only small CSPs in a very reduced set of signals (Leu493, Gly513 and Trp542)(data not shown).
Overall, these biophysical analyses support that while different factors affecting the activity, structure and 
dynamics of NQO1 (including p.P187S, cofactors and inhibitors, or the CTD) may somewhat change the binding 
mode to SAMp73, this interaction is not prevented by any of the aforementioned factors. Moreover, our results 
also provide the first structural insights into the interaction between p73α and NQO1.
The CTD largely determines fast proteasomal degradation of p.P187S. The highly dynamic CTD 
of p.P187S appears to act as an efficient initiation site for its proteasomal degradation24. Consistently, removal of 
the CTD had significant effects on protein levels and degradation rates upon expression in an eukaryotic expres-
sion cell free system (Fig. 9). In pulse synthesis, p.P187S showed 2.4-fold lower protein levels compared with WT 
as full-length proteins, while removal of the CTD (i.e. in Δ 50 variants) caused a much larger decrease in WT 
protein levels than in p.P187S (3-fold vs. 1.5-fold; Fig. 9A–C). From chase experiments, we also observed a strong 
correlation between protein levels and degradation rates after a pulse of synthesis, supporting that proteasomal 
degradation rates strongly determine protein steady-state levels (Fig. 9B–E). Accordingly, p.P187S was degraded 
1.75-fold faster than NQO1 WT (Fig. 9B,D), and removal of the CTD accelerated degradation of WT by 2.5-fold, 
but only that of p.P187S by 1.3-fold (Fig. 9B,D). These results show that removal of the CTD destabilizes NQO1 
WT to a larger extent than the polymorphism, and therefore, the highly flexible CTD of p.P187S accelerates 
NQO1 proteasomal degradation. The enhanced degradation of Δ 50-NQO1 is likely to be associated to its higher 
flexibility compared to that of full-length enzyme, as supported by our MD simulations (Fig. 7).
Discussion
In this work, we show that the CTD plays key functional and regulatory roles in NQO1, and remarkably, how it is 
crucial for the manifestation of the multiple deleterious effects of the cancer-associated p.P187S polymorphism. 
As expected from previous crystallographic evidence, the CTD is important for NQO1 activity, providing proper 
orientation of the coenzymes (FAD and NADH) and the substrate. Unexpectedly, we provide evidence for the 
existence of long-range communication between the p.P187S site and functional sites such as the CTD and the 
Figure 9. Pulse-chase experiments in rabbit reticulocytes. (A) Synthesis pulses of NQO1 variants. (B) Chase 
experiments. (C) Protein levels after synthesis pulses (normalized vs. NQO1 WT levels); (D) Semilogarithmic 
plots for chase kinetics; (E) correlation between protein levels after synthesis pulses and degradation half-lives. 
Data are mean ± s.d. from three independent experiments.
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FAD binding sites, that we therefore refer to as the allosteric interaction network (Fig. 10). For NQO1 WT, we 
propose that this allosteric network contributes to its very high affinity for FAD as well as binding negative coop-
erativity, which are largely perturbed upon removal of the CTD. In addition, p.P187S may disturb this allosteric 
network promoting dynamic and structural alterations in the FAD binding site and the CTD and consequently 
reducing the binding affinity for FAD and dicoumarol. Perturbed allosteric communication between FAD bind-
ing sites and the CTD is further supported by the strong effect of CTD withdrawal in p.P187S, that eliminates 
the effects of the polymorphism on FAD binding site dynamics of the apo-state thus increasing its FAD binding 
affinity. Interestingly, other functional sites (such as the binding site for p73α ) may not be strongly connected to 
this allosteric interaction network involving the FAD binding site, the CTD and the p.P187S site (Fig. 10).
FAD and dicoumarol cause different conformational changes upon binding to WT and p.P187S. FAD binding 
to NQO1 WT causes larger changes in hydrodynamic volume, secondary structure and intrinsic dynamics than 
those in p.P187S, while dicoumarol binding has larger effects on the conformation of holo-p.P187S (Figs 2,6 and 
7, and ref. 24). These different conformational changes are mostly associated with the more dynamic and less 
structured CTD in the holo-state of p.P187S. Accordingly, structural calculations applied to dicoumarol bind-
ing energetics supported a much larger conformational change in the CTD for p.P187S (energetically resem-
bling folding of a small protein). This scenario is consistent with a pre-existing conformational equilibrium in 
which apo-NQO1 mainly populates states non-competent for FAD binding, and that the presence of FAD shifts 
the conformational equilibrium towards less dynamic and more structured FAD binding competent states (this 
population-shift is macroscopically observed as a conformational change). For dicoumarol binding, the conforma-
tional change caused in p.P187S is larger than that of WT, due to the flexible and partially unstructured CTD of 
the polymorphism in the unbound holo-state, that must undergo large changes in structure and dynamics to reach 
the binding competent state (thus penalizing its binding). Importantly, we also provide evidence that p.P187S 
affects locally functional dynamics of the unbound conformational ensembles, particularly at the FAD binding of 
the apo-state (relevant for FAD interaction) and the CTD of the holo-state (important for dicoumarol binding). 
Unfortunately, the available data do not allow distinguish between induced-fit or conformational-selection mecha-
nisms for FAD and dicoumarol binding to NQO1, that distinction would depend on whether binding competent 
states are significantly populated in the conformational equilibrium of apo-NQO112.
Proteasomal degradation of proteins is central to understanding the effect of genetic variations in 
loss-of-function inherited diseases20. In this context, dynamic or unstructured regions are key to drive recogni-
tion and efficient degradation by 20S and 26S proteasomes8,9. NQO1 is an excellent model to investigate protea-
somal protein degradation, with particularly interesting roles of genetic variations, ligand binding and protein 
stability and dynamics in the modulation of degradation rates8,22,24,36,40. In the present work, we show that the 
enhanced dynamics of the CTD is key to determining the proteasomal degradation of NQO1, and furthermore, 
that once the CTD is removed (for instance by proteasomal degradation of this domain), the remaining protein 
is much more flexible and efficiently degraded (Figs 7 and 9). This result supports a step-wise directional deg-
radation of NQO1 through its C-terminal end. More generally, our work highlights the idea of investigating 
mutational effects on protein dynamics as well as on global stability to assess the role of enhanced proteasomal 
degradation in loss-of-function genetic diseases.
Figure 10. Schematic representation of the long-range communication between functional sites in NQO1 
WT and p.P187S (allosteric interaction network). In NQO1 WT, the allosteric network between the P187 site, 
FAD binding site and CTD may contribute to the high-affinity cooperative binding of FAD and consequent 
structural and dynamic effects on the CTD upon binding. In NQO1 p.P187S, the S187 site affects FAD binding 
by changing the dynamics of its binding site and preventing structural and dynamic changes on CTD upon FAD 
binding. Removal of the CTD abolishes the dynamic effects of the S187 site on the FAD binding site. In all cases, 
alterations in this allosteric network seem to have a weak effect on the interaction site with p73α .
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To further understand the roles of NQO1 in human physiology and pathology, we must know the molecular 
and structural basis of its ability to interact with cell cycle regulators such as p53 and p73α and its inhibitory effect 
on the 20S proteasome26,36. Here, we present novel structural insights on the weak NQO1:oncosuppressor inter-
action. Importantly, we show that neither the CTD nor an active NQO1 is strictly required to interact with p73α , 
even though different ligands bound to NQO1 may modulate the intrinsically low affinity of this interaction, con-
sistent with previous biochemical studies on these protein:protein interactions29,30,37,41. Interestingly enough, our 
studies show that the region of SAMp73 involved in binding to NQO1 is the same implicated in binding to other 
molecules at SAM domains: the so-called middle-loop-end-helix polypeptide-patch, with the fifth α -helix and 
the short 310 helix as critical elements of secondary structure42–45. We must finally note that the available evidences 
support that intracellular destabilization of these oncosuppressors by p.P187S just mirrors its own intracellular 
instability rather than its inability to engage in these protein:protein interactions24,29,36,40.
In conclusion, the present work lends support to the existence of complex allosteric communication 
between functional sites in a two-domain oligomeric protein with a remarkable functional chemistry and how 
a disease-associated single amino acid change may affect different functional sites through perturbation of 
allosteric networks. Due to the high prevalence of missense mutations affecting protein stability, activity and 
regulation19,21,46–48, our mutational strategy combined with functional, structural, energetic and dynamic studies 
could help to decipher complex disease-associated mutational effects in many other loss-of-function genetic dis-
eases and to identify structural targets for therapeutic correction.
Materials and Methods
Protein expression and purification. The introduction of full-length NQO1 variants into the pET46 Ek/
LIC vector have been recently described22. Site-directed mutagenesis was carried out using the QuikChange kit 
(Stratagene) to introduce a codon stop at the 225th residue of the coding sequence of NQO1 and to produce 
Δ 50-NQO1 variants. All coding sequences were verified by DNA sequencing. Competent E. coli BL21 (DE3) 
cells were transformed with these plasmids and used to express NQO1 and Δ 50-NQO1 proteins following 
previously described procedures22. Samples were buffer exchanged to 50 mM HEPES-KOH pH 7.4 and stored at 
− 80 °C after flash-freezing in liquid nitrogen. Protein concentrations were measured spectrophotometrically 
using ε 280nm = 47900 M−1·cm−1. Correction for pre-bound FAD and preparation of apo-proteins were carried 
out as described22. NQO1 samples in different ligation states are designated as follows: apo-NQO1 (no ligand 
bound), NQO1 (as purified, partially saturated with FAD22), holo-NQO1 (saturated with FAD) and holo-
NQO1 + dic (saturated with FAD and dicoumarol). FAD and dicoumarol stock solutions were prepared as 
previously described22,24.
SAMp73 was produced and purified as described49. For 15N-SAMp73 expression, cells were grown in M9 min-
imal media, with 1 gr per liter of 15NH4Cl, supplemented with vitamins, and purified as the unlabelled protein49.
Isothermal titration calorimetry (ITC). Experiments were performed in a ITC200 microcalorimeter 
(Malvern) with a cell volume of 0.205 mL. Titrations were performed in 50 mM HEPES–KOH pH 7.4. FAD titra-
tions were carried out using 3.5–5 μ M Δ 50-apo-NQO1 variants (in dimer units) in the cell and 125 μ M FAD in 
the titration syringe by performing 20–25 injections of 1.5 μ L each 180 s. Dicoumarol titrations were carried out 
using 5 μ M NQO1 or Δ 50-NQO1 holo-variants (in monomer) supplemented with FAD (10 μ M), and 100 μ M 
dicoumarol + 10 μ M FAD in the syringe by performing 20–25 injections of 1.5 μ L each 180 s. Data were cor-
rected for heats of dilution by performing titrations into buffer. After peak integration, binding isotherms were 
fitted using a model for identical and independent type of sites using the software provided by the manufacturer. 
Thermodynamic parameters are presented as the mean from two independent titrations.
Far-UV circular dichroism (CD) spectroscopy. Circular dichroism (CD) was measured in Jasco J-710 or 
J-815 spectropolarimeters thermostatized using a Peltier element. NQO1 CD spectra were determined in 50 mM 
K-phosphate pH 7.4 at 25 °C, typically in a 195–260 nm range and using 50–100 nm/min scan rates. Samples 
of NQO1 proteins were prepared at 4 μ M concentration in monomer, and 6 scans were acquired and averaged. 
In some cases, 10 μ M FAD and 10 μ M FAD + 10 μ M dicoumarol were added. Experiments in the presence of 
SAMp73 and WT NQO1 were carried out at a equimolar concentration (10 μ M in protein monomer) of each 
protein at 25 °C in 25 mM phosphate buffer pH 6.9. In all cases, appropriate blanks in the absence of proteins were 
acquired and subtracted from those of protein samples.
For thermal denaturation studies, NQO1 samples (4 μ M in protein monomer) were equilibrated for 10 min 
at 20 °C in the absence or presence of ligands (50 μ M FAD and 50 μ M FAD + 50 μ M dicoumarol) and thermal 
scans were performed up to 70–80 °C at a 2 °C/min scan rate. For sake of comparison, denaturation curves were 
normalized using pre- and post-transition baselines, and the half-denaturation temperature (Tm) was determined 
as the temperature at which half of the native signal was lost.
Dynamic light scattering. Dynamic light scattering (DLS) was carried out in a DynaPro MSX instrument 
(Wyatt) using 1.5 mm path length cuvettes and 10 μ M protein (in monomer units) in 50 mM HEPES-KOH pH 
7.4 at 25 °C. 30 measurements were acquired for each NQO1 protein, in the absence or presence of ligands (20 μ M 
FAD and 20 μ M FAD + 20 μ M dicoumarol) in three to six independent replicates, averaged and used to determine 
the hydrodynamic radius and polydispersity using the average autocorrelation function and assuming a spherical 
shape.
Fluorescence experiments. Fluorescence spectra were acquired in a Varian Cary Eclipse spectrofluorim-
eter (Agilent, USA) interfaced with a Peltier unit. The excitation wavelengths were either 280 or 295 nm. The 
emission fluorescence was collected between 300–400 nm. Excitation and emission slits were 5 nm. Spectra 
were corrected by subtracting the corresponding blanks. Experiments were acquired with 2 μ M SAMp73 or 
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NQO1-WT (in protein monomer), or a equimolar mixture of them, in 25 mM phosphate buffer pH 6.9 at 25 °C. 
NADH was added at a final concentration of 1 mM.
For titration experiments, a concentration of 4.2 μ M NQO1-WT (in monomer) was used. Increasing concen-
trations of SAMp73 (from 0 to 8 μ M) were added. The rest of the experimental set was the same as above.
Activity measurements. NQO1 activity was measured in 50 mM HEPES-KOH pH 7.4. A reaction mix-
ture containing recombinant NQO1 and 0.5 mM NADH was incubated at 30 °C for 5 min in 1-cm path length 
quartz cuvettes in a thermostatized Agilent 8453 diode array spectrophotometer. The reaction was triggered by 
the addition of 70 μ M DCPIP (2,6-dichlorophenolindophenol) as the electron acceptor. Initial reaction rates were 
determined from changes in A600nm resulting from the reduction of DCPIP and corrected for the non-enzymatic 
reaction. To determine the kinetic parameters, NQO1 enzymes were incubated with a FAD excess (1 μ M final 
concentration), NADH was kept constant at 1 mM and DCPIP was varied from 7–50 μ M or, DCPIP was man-
tained at 50 μ M and NADH was varied from 0.05–8 mM. Blanks in the absence of proteins were determined 
and subtracted from the reaction with NQO1. The NQO1 concentration used varied depending on the variant 
to ensure linearity over time and protein concentration: 1 nM (WT with and without added FAD, p.P187S with 
FAD), 25–50 nM (p.P187S without added FAD), 200–600 nM (Δ 50-WT and Δ 50-p.P187S, with and without 
added FAD). The specific activity was calculated using a ε 600nm = 21000 M−1·cm−1 for DCPIP. kcat and KM values 
were determined using the Michaelis-Menten equation.
Proteolysis by thermolysin. Thermolysin from Bacillus thermoproteolyticus rokko was purchased from 
Sigma-Aldrich, disolved in 50 mM HEPES-KOH 10 mM CaCl2 pH 7.4, stored at − 80 °C and its concentration 
measured spectrophotometrically using a ε 280nm = 66086 M−1·cm−1. Proteolysis was performed at 25 °C in 50 mM 
HEPES-KOH 10 mM CaCl2 pH 7.4 using 20 μ M Δ 50-NQO1 (in monomer units), and the reaction was initiated 
by the addition of thermolysin at a final concentration of 0.1 μ M. Proteolysis reactions were performed using 
Δ 50-NQO1 as apo-proteins, upon addition of 100 μ M FAD or 100 μ M FAD and dicoumarol. Samples were with-
drawn at different times, quenched with EDTA (20 mM final concentration) and denatured using Laemmli´s 
buffer at 95 °C for 5 min. Samples were resolved in 12% acrylamide SDS-PAGE gels, stained with Coomassie Blue 
and densitometered using ImageJ (http://rsbweb.nih.gov/ij/). After normalization of the intensities using that of 
the sample lacking thermolysin, the decay of the native band was analyzed using a single exponential function 
that yields the proteolysis rate constant k.
Mass spectrometry. To analyze the proteolysis products of Δ 50-WT, the apo-protein (10 μ M in monomer 
units) was incubated at 25 °C in 50 mM HEPES-KOH 10 mM CaCl2 pH 7.4 with 100 nM thermolysin at three dif-
ferent conditions: (i) no ligand and 1 min reaction; (ii) FAD 100 μ M, 16 min; (iii) FAD and dicoumarol (100 μ M 
each) for 4 hours. The reaction volume was 150 μ L. The reaction was stopped by addition of EDTA 20 mM.
125 μ L of the final solution were exchanged to water using VIVAspin 500 filters (10 kDa) by two 
dilution-concentration cycles and submitted for High performance liquid chromatography/electrospray 
ionization mass spectrometry (HPLC/ESI-MS) to the High-resolution mass spectrometry unit, Centro de 
Instrumentación Científica (University of Granada). HPLC/ESI-MS was performed in a Acquity UPLC system 
(Waters), using a water/formic acid, acetonitrile/formic acid (each at 0.1%) gradient in a Acquity UPLC® BEH300 
C4 column (2.1 × 50 mm, Waters) coupled to a Q-TOF Synapt62 HDMS (Waters).
10 μ L of the final solution were mixed with an equal volume of Laemmli's buffer (x2), denatured at 95 °C and 
loaded into a SDS-PAGE gel (12% acrylamide). Two bands (#1 and #2) were manually excised from gels and sub-
mitted for analyses to the Proteomics Unit, Complutense University of Madrid, a member of ProteoRed network. 
Samples were in-gel reduced, alkylated and digested with trypsin, and after digestion, 1 μ l of the supernatant 
was spotted onto a MALDI target plate, allowed to air-dry, and mixed with α -cyano-4-hydroxy-cinnamic acid 
matrix (Sigma) in 50% acetonitrile, and allowed again to air-dry at room temperature. MALDI-TOF MS analyses 
were performed in a 4800 Plus Proteomics Analyzer MALDI-TOF/TOF mass spectrometer (Applied Biosystems, 
MDS Sciex, Toronto, Canada). The MALDI-TOF/TOF operated in positive reflector mode with an accelerating 
voltage of 20000 V. All mass spectra were calibrated internally using peptides from the auto digestion of trypsin. 
Peptides of interest were subjected to MS/MS sequencing analyses using the 4800 plus Proteomics Analyzer. 
From MS spectra, suitable precursors were selected to be fragmented by CID (Collision Induced Disociation 
with atmospheric gas) using a 1 KV ion reflector operate method and a precursor mass window of ± 4 Da. The 
Swissprot database (http://www.uniprot.org/help/uniprotkb) was used for protein identification without taxon-
omy restriction, and a home-made database with the sequence of recombinant Δ 50-WT NQO1 was searched 
using MASCOT 2.3 (www.matrixscience.com) through the Global Protein Server v 3.6 from ABSciex, using the 
following parameters: enzyme, semitrypsin; carbamidomethyl cystein as fixed modification and oxidized methio-
nine as variable modification; peptide mass tolerance, 50 ppm (PMFSearch) – 100 ppm (Combined search); up 
to 2 missed trypsin cleavage site; MS-MS fragments tolerance, 0.3 Da. The parameters for the combined search 
(Peptide mass fingerprint plus MS-MS spectra) were the same as described above. In any protein identification, 
the probability scores were greater than the score fixed by Mascot as significant with a p value < 0.05.
Molecular dynamics simulations. We performed molecular dynamics simulations of Δ 50-NQO1 WT 
and p.P187S in the apo-state and in complex with FAD and/or dicoumarol. The simulations of full-length NQO1 
used as comparison are described in ref. 24. Systems were prepared in dimeric state on basis of crystal structures 
of the complex with FAD (PDB: 1D4A50) and the ternary complex (PDB: 2F1O32). Proteins were protonated for 
simulation using protonate3d and mutated as well as truncated in MOE51.
Simulations were performed using the GPU implementation of pmemd in Amber1252. Protein residues were 
parametrized using the Amber forcefield 99SB-ILDN53. FAD and dicumarol parameters were taken from an 
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earlier study24. After employing an extensive equilibration protocol54, unrestrained systems were sampled for 
100 ns in NpT ensemble and 5,000 equal-spaced snapshots were saved to trajectory.
After ensuring thermodynamic and structural stability of simulations, we analyzed resulting conformational 
ensembles using cpptraj from AmberTools33. We analyzed B-factors of Cα atoms (derived from root mean 
squared fluctuations along the simulations) after a single alignment to all Cα atoms as a metric for global flexi-
bility. Additionally, we extracted dihedral angles of the protein backbone and calculated dihedral entropies based 
on resulting distributions after employing parameter-free kernel density estimation55. Integration over proba-
bility densities yields a thermodynamic entropy depicting a metric for local intrinsic flexibility of the protein 
backbone56. Independent dihedral entropies over all three backbone torsion angles were summed to yield a total 
dihedral entropy per residue. All values are presented as arithmetic average over two dimer sub-units. Interface 
residues were defined as all residues with at least one atom closer than 3 Å to the adjacent sub-unit.
NMR spectroscopy. The NMR data were acquired at 20 °C on a Bruker Avance DRX-500 spectrometer 
equipped with a triple-resonance probe and z-gradients. Proteins and ligands were prepared in 50 mM 
phosphate buffer pH 6.9. The 15N-labelled SAMp73 concentration was in all cases ~200 μ M, NQO1 variants 
(as purified) were prepared at ~300 μ M. When necessary, ligands were added to a final concentration of 3 mM 
(dicoumarol) or 8 mM (FAD or NADH). The 2D 1H-15N HSQC (heteronuclear single-quantum coherence) 
experiments57 were acquired in the following conditions: (i) isolated 15N-SAMp73; (ii) 15N- SAMp73 with NQO1 
WT; (iii) 15N-SAMp73 with NQO1 WT + NADH; (iv) 15N-SAMp73 with Δ 50-NQO1 WT; (v) 15N-SAMp73 with 
Δ 50-NQO1 WT + FAD; (vi) 15N-SAMp73 with Δ 50-NQO1 WT + FAD + NADH; (vii) 15N-SAMp73 with NQO1 
P187S; (viii) 15N-SAMp73 with NQO1 P187S + FAD; (ix) 15N-SAMp73 with NQO1 P187S + FAD + NADH; and, 
(x) 15N-SAMp73 with NQO1 WT + dicoumarol (with stoichiometric amounts of dicoumarol). Samples containing 
Δ 50-NQO1 led to precipitation during the experiments; experiments in the presence of dicoumarol also led to 
precipitation. Control experiments were acquired with 15N-SAMp73 with FAD and 15N-SAMp73 with NADH; 
no differences in either chemical shifts or signal broadening were observed when compared with the spectrum of 
isolated 15N-SAMp73 (BMRB number 4413)58.
Spectra were acquired in the phase sensitive mode. Frequency discrimination in the indirect dimensions was 
achieved by using the echo/antiecho-TPPI method. The spectra were acquired with 2 K complex points in the 
1H dimension, 128 complex points in the 15N dimension, and 200 scans. The carrier of the 1H dimension was set 
at the water frequency, and that of 15N at 120 ppm. The spectral widths used were 10 and 35 ppm in the 1H and 
15N dimensions, respectively. Water was suppressed with the WATERGATE sequence59. Data were zero-filled 
to double the number of original points in both dimensions, apodized with shifted squared sine-bell functions 
in the two dimensions and Fourier transformed with the program TopSpin 1.3 (Bruker). The assignment of the 
spectrum of SAMp73 under our conditions was carried out by comparison of the chemical shifts of the signals, 
with that previously published58.
To analyse the differences between the 2D 1H-15N HSQC spectra of isolated SAMp73 and of the complexes, 
the chemical shift perturbation (CSP) was used. CSP was calculated as: δ δ= ∆ + . ∆CSP ( ) 0 1( )H N
2 2 , where 
Δ δH is the difference in chemical shift of the amide protons of isolated SAMp73 and that of SAMp73 in the corre-
sponding complex; and Δ δN is the difference in chemical shift of 15N resonances of isolated SAMp73 and that of 
SAMp73 in the complex. Only variations in residues with CSP ≥ 0.01 ppm were considered significant. 
Broadening of signals was measured in comparison with the internal reference of Ala530. Changes in cross-peak 
intensity were considered significant when variations between the spectrum of isolated SAMp73 and that in the 
presence of NQO1 species were larger than 10%.
Expression studies in a cell-free system. Expression in a rabbit reticulocyte cell-free system (TnT sys-
tem, Promega) was performed at 30 °C for 30 min using 35S-Met and NOQ1 cDNA variants subcloned in pCIneo 
plasmids (Promega; 1 μ g plasmid/reaction). Protein synthesis was stopped with 100 μ g/ml cycloheximide, and 
kept at 30 °C for various chasing times. Aliquots were denatured in Laemmli’s buffer and analyzed by SDS-PAGE 
and fluorography. The autoradiograms were scanned in a Molecular Imager FX (Bio-Rad) and the software 
LabImager (Bio-Rad) was used to measure the band volume adjusted to background. All experiments were per-
formed three independent times and data are presented as mean ± s.d.
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